Search

everythinglearnresearchcommunity

for

Search:↓

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Differences in enzyme activity and androgen receptors in hair follicles may explain why hair loss appears differently in men and women.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

The inhibitor DPP can promote hair growth.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

A mutation in the vitamin D receptor causes severe resistance to vitamin D, affecting bone health but not hair growth.

Spironolactone may help women with hidradenitis suppurativa.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

Idiopathic hirsutism might not be truly idiopathic but could be an early stage of hyperandrogenic disorders.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Three new gene mutations cause rickets and hair loss, treatable with high calcium and calcidol, but hair regrowth is rare.

A new gene mutation causes hereditary coproporphyria with reduced enzyme activity.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

A new compound effectively inhibits human 5α-reductase 1.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Hair analysis can effectively assess long-term hormone activity in young children.